In Singapore, adverse drug reactions are monitored post-registration through the Health Sciences Authority’s Vigilance and Compliance Branch. Healthcare professionals and consumers report adverse reactions via the online platform, Vigilance and Compliance System (VigiFlow). Data is analyzed to ensure drug safety, and necessary regulatory actions are taken to protect public health.
